AiPing Pharmaceutical Inc
FDA Approved Drugs

AiPing Pharmaceutical Inc

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued RX
  • Total Records 141
  • Latest Approval Date Jun 24, 2026
  • Data Source FDA
  • First Approval Date Jan 01, 1982
All
141
View
Discontinued
55
View
RX
86
View
Company Overview

Company

AiPing Pharmaceutical Inc

Country

U.S.A

Social Profiles

Company Snapshot

AiPing Pharmaceutical Inc

350 W Wireless Boulevard\nHauppauge, NY

U.S.A

www.aipingpharmaceutical.com/ solutions@aipingpharma.com View on Map
FDA Approved Drug Records ( 141 records )
2006
21 Dec
Discontinued Application: 76867

Drug Name

ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE

Product Number

1

Dosage Form

-

Strength

EQ 0.083% BASE;0.017%

Approval Date

2006-12-21

76867 / 1

Active Ingredient

ALBUTEROL SULFATE; IPRATROPIUM BROMIDE

Application Number

76867

Product Number

1

Dosage Form

-

Strength

EQ 0.083% BASE;0.017%

Approval Date

2006-12-21

Regulatory Status

Discontinued

1985
31 Dec
Discontinued Application: 70268

Drug Name

ALLOPURINOL

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

1985-12-31

70268 / 1

Active Ingredient

ALLOPURINOL

Application Number

70268

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

1985-12-31

Regulatory Status

Discontinued

2020
07 Apr
RX Application: 212654

Drug Name

AMITRIPTYLINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2020-04-07

212654 / 1

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE

Application Number

212654

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2020-04-07

Regulatory Status

RX

2021
29 Sep
RX Application: 212654

Drug Name

AMITRIPTYLINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2021-09-29

212654 / 2

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE

Application Number

212654

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2021-09-29

Regulatory Status

RX

2021
29 Sep
RX Application: 212654

Drug Name

AMITRIPTYLINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

2021-09-29

212654 / 3

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE

Application Number

212654

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

2021-09-29

Regulatory Status

RX

2021
29 Sep
RX Application: 212654

Drug Name

AMITRIPTYLINE HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

75MG

Approval Date

2021-09-29

212654 / 4

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE

Application Number

212654

Product Number

4

Dosage Form

-

Strength

75MG

Approval Date

2021-09-29

Regulatory Status

RX

2021
29 Sep
RX Application: 212654

Drug Name

AMITRIPTYLINE HYDROCHLORIDE

Product Number

5

Dosage Form

-

Strength

100MG

Approval Date

2021-09-29

212654 / 5

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE

Application Number

212654

Product Number

5

Dosage Form

-

Strength

100MG

Approval Date

2021-09-29

Regulatory Status

RX

2021
29 Sep
RX Application: 212654

Drug Name

AMITRIPTYLINE HYDROCHLORIDE

Product Number

6

Dosage Form

-

Strength

150MG

Approval Date

2021-09-29

212654 / 6

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE

Application Number

212654

Product Number

6

Dosage Form

-

Strength

150MG

Approval Date

2021-09-29

Regulatory Status

RX

2024
02 Apr
RX Application: 214901

Drug Name

ARFORMOTEROL TARTRATE

Product Number

1

Dosage Form

-

Strength

EQ 0.015MG BASE/2ML

Approval Date

2024-04-02

214901 / 1

Active Ingredient

ARFORMOTEROL TARTRATE

Application Number

214901

Product Number

1

Dosage Form

-

Strength

EQ 0.015MG BASE/2ML

Approval Date

2024-04-02

Regulatory Status

RX

2017
09 Jan
Discontinued Application: 91279

Drug Name

ARIPIPRAZOLE

Product Number

1

Dosage Form

-

Strength

2MG

Approval Date

2017-01-09

91279 / 1

Active Ingredient

ARIPIPRAZOLE

Application Number

91279

Product Number

1

Dosage Form

-

Strength

2MG

Approval Date

2017-01-09

Regulatory Status

Discontinued

2017
09 Jan
Discontinued Application: 91279

Drug Name

ARIPIPRAZOLE

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2017-01-09

91279 / 2

Active Ingredient

ARIPIPRAZOLE

Application Number

91279

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2017-01-09

Regulatory Status

Discontinued

2017
09 Jan
Discontinued Application: 91279

Drug Name

ARIPIPRAZOLE

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2017-01-09

91279 / 3

Active Ingredient

ARIPIPRAZOLE

Application Number

91279

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2017-01-09

Regulatory Status

Discontinued

2017
09 Jan
Discontinued Application: 91279

Drug Name

ARIPIPRAZOLE

Product Number

4

Dosage Form

-

Strength

15MG

Approval Date

2017-01-09

91279 / 4

Active Ingredient

ARIPIPRAZOLE

Application Number

91279

Product Number

4

Dosage Form

-

Strength

15MG

Approval Date

2017-01-09

Regulatory Status

Discontinued

2017
09 Jan
Discontinued Application: 91279

Drug Name

ARIPIPRAZOLE

Product Number

5

Dosage Form

-

Strength

20MG

Approval Date

2017-01-09

91279 / 5

Active Ingredient

ARIPIPRAZOLE

Application Number

91279

Product Number

5

Dosage Form

-

Strength

20MG

Approval Date

2017-01-09

Regulatory Status

Discontinued

2017
09 Jan
Discontinued Application: 91279

Drug Name

ARIPIPRAZOLE

Product Number

6

Dosage Form

-

Strength

30MG

Approval Date

2017-01-09

91279 / 6

Active Ingredient

ARIPIPRAZOLE

Application Number

91279

Product Number

6

Dosage Form

-

Strength

30MG

Approval Date

2017-01-09

Regulatory Status

Discontinued

1988
15 Jul
RX Application: 72304

Drug Name

ATENOLOL

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

1988-07-15

72304 / 1

Active Ingredient

ATENOLOL

Application Number

72304

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

1988-07-15

Regulatory Status

RX

1992
31 Jul
RX Application: 72304

Drug Name

ATENOLOL

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

1992-07-31

72304 / 2

Active Ingredient

ATENOLOL

Application Number

72304

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

1992-07-31

Regulatory Status

RX

1988
18 Jul
RX Application: 72304

Drug Name

ATENOLOL

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

1988-07-18

72304 / 3

Active Ingredient

ATENOLOL

Application Number

72304

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

1988-07-18

Regulatory Status

RX

1990
31 May
RX Application: 72302

Drug Name

ATENOLOL AND CHLORTHALIDONE

Product Number

1

Dosage Form

-

Strength

100MG;25MG

Approval Date

1990-05-31

72302 / 1

Active Ingredient

ATENOLOL; CHLORTHALIDONE

Application Number

72302

Product Number

1

Dosage Form

-

Strength

100MG;25MG

Approval Date

1990-05-31

Regulatory Status

RX

1990
31 May
RX Application: 72302

Drug Name

ATENOLOL AND CHLORTHALIDONE

Product Number

2

Dosage Form

-

Strength

50MG;25MG

Approval Date

1990-05-31

72302 / 2

Active Ingredient

ATENOLOL; CHLORTHALIDONE

Application Number

72302

Product Number

2

Dosage Form

-

Strength

50MG;25MG

Approval Date

1990-05-31

Regulatory Status

RX

1996
12 Dec
RX Application: 40103

Drug Name

BENZTROPINE MESYLATE

Product Number

1

Dosage Form

-

Strength

0.5MG

Approval Date

1996-12-12

40103 / 1

Active Ingredient

BENZTROPINE MESYLATE

Application Number

40103

Product Number

1

Dosage Form

-

Strength

0.5MG

Approval Date

1996-12-12

Regulatory Status

RX

1996
12 Dec
RX Application: 40103

Drug Name

BENZTROPINE MESYLATE

Product Number

2

Dosage Form

-

Strength

1MG

Approval Date

1996-12-12

40103 / 2

Active Ingredient

BENZTROPINE MESYLATE

Application Number

40103

Product Number

2

Dosage Form

-

Strength

1MG

Approval Date

1996-12-12

Regulatory Status

RX

1996
12 Dec
RX Application: 40103

Drug Name

BENZTROPINE MESYLATE

Product Number

3

Dosage Form

-

Strength

2MG

Approval Date

1996-12-12

40103 / 3

Active Ingredient

BENZTROPINE MESYLATE

Application Number

40103

Product Number

3

Dosage Form

-

Strength

2MG

Approval Date

1996-12-12

Regulatory Status

RX

2015
16 Dec
RX Application: 202087

Drug Name

BUSPIRONE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2015-12-16

202087 / 1

Active Ingredient

BUSPIRONE HYDROCHLORIDE

Application Number

202087

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2015-12-16

Regulatory Status

RX

2015
16 Dec
RX Application: 202087

Drug Name

BUSPIRONE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2015-12-16

202087 / 2

Active Ingredient

BUSPIRONE HYDROCHLORIDE

Application Number

202087

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2015-12-16

Regulatory Status

RX

2015
16 Dec
RX Application: 202087

Drug Name

BUSPIRONE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

15MG

Approval Date

2015-12-16

202087 / 3

Active Ingredient

BUSPIRONE HYDROCHLORIDE

Application Number

202087

Product Number

3

Dosage Form

-

Strength

15MG

Approval Date

2015-12-16

Regulatory Status

RX

2015
16 Dec
RX Application: 202087

Drug Name

BUSPIRONE HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

30MG

Approval Date

2015-12-16

202087 / 4

Active Ingredient

BUSPIRONE HYDROCHLORIDE

Application Number

202087

Product Number

4

Dosage Form

-

Strength

30MG

Approval Date

2015-12-16

Regulatory Status

RX

2025
03 Jul
RX Application: 202087

Drug Name

BUSPIRONE HYDROCHLORIDE

Product Number

5

Dosage Form

-

Strength

7.5MG

Approval Date

2025-07-03

202087 / 5

Active Ingredient

BUSPIRONE HYDROCHLORIDE

Application Number

202087

Product Number

5

Dosage Form

-

Strength

7.5MG

Approval Date

2025-07-03

Regulatory Status

RX

2023
27 Jan
RX Application: 214442

Drug Name

CAPTOPRIL

Product Number

1

Dosage Form

-

Strength

12.5MG

Approval Date

2023-01-27

214442 / 1

Active Ingredient

CAPTOPRIL

Application Number

214442

Product Number

1

Dosage Form

-

Strength

12.5MG

Approval Date

2023-01-27

Regulatory Status

RX

2023
27 Jan
RX Application: 214442

Drug Name

CAPTOPRIL

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

2023-01-27

214442 / 2

Active Ingredient

CAPTOPRIL

Application Number

214442

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

2023-01-27

Regulatory Status

RX

2023
27 Jan
RX Application: 214442

Drug Name

CAPTOPRIL

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

2023-01-27

214442 / 3

Active Ingredient

CAPTOPRIL

Application Number

214442

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

2023-01-27

Regulatory Status

RX

2023
27 Jan
RX Application: 214442

Drug Name

CAPTOPRIL

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

2023-01-27

214442 / 4

Active Ingredient

CAPTOPRIL

Application Number

214442

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

2023-01-27

Regulatory Status

RX

2014
11 Mar
Discontinued Application: 202277

Drug Name

CETIRIZINE HYDROCHLORIDE ALLERGY

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2014-03-11

202277 / 2

Active Ingredient

CETIRIZINE HYDROCHLORIDE

Application Number

202277

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2014-03-11

Regulatory Status

Discontinued

2014
11 Mar
Discontinued Application: 202277

Drug Name

CETIRIZINE HYDROCHLORIDE ALLERGY

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

2014-03-11

202277 / 4

Active Ingredient

CETIRIZINE HYDROCHLORIDE

Application Number

202277

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

2014-03-11

Regulatory Status

Discontinued

2014
11 Mar
Discontinued Application: 202277

Drug Name

CETIRIZINE HYDROCHLORIDE HIVES

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2014-03-11

202277 / 1

Active Ingredient

CETIRIZINE HYDROCHLORIDE

Application Number

202277

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2014-03-11

Regulatory Status

Discontinued

2014
11 Mar
Discontinued Application: 202277

Drug Name

CETIRIZINE HYDROCHLORIDE HIVES

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2014-03-11

202277 / 3

Active Ingredient

CETIRIZINE HYDROCHLORIDE

Application Number

202277

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2014-03-11

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 87381

Drug Name

CHLORTHALIDONE

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

1982-01-01

87381 / 1

Active Ingredient

CHLORTHALIDONE

Application Number

87381

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

1982-01-01

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 87381

Drug Name

CHLORTHALIDONE

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

1982-01-01

87381 / 2

Active Ingredient

CHLORTHALIDONE

Application Number

87381

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

1982-01-01

Regulatory Status

Discontinued

2022
21 Jan
RX Application: 214877

Drug Name

CHOLESTYRAMINE

Product Number

1

Dosage Form

-

Strength

EQ 4GM RESIN/PACKET

Approval Date

2022-01-21

214877 / 1

Active Ingredient

CHOLESTYRAMINE

Application Number

214877

Product Number

1

Dosage Form

-

Strength

EQ 4GM RESIN/PACKET

Approval Date

2022-01-21

Regulatory Status

RX

2022
21 Jan
RX Application: 214877

Drug Name

CHOLESTYRAMINE

Product Number

2

Dosage Form

-

Strength

EQ 4GM RESIN/SCOOPFUL

Approval Date

2022-01-21

214877 / 2

Active Ingredient

CHOLESTYRAMINE

Application Number

214877

Product Number

2

Dosage Form

-

Strength

EQ 4GM RESIN/SCOOPFUL

Approval Date

2022-01-21

Regulatory Status

RX

2004
09 Jun
RX Application: 76593

Drug Name

CIPROFLOXACIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 250MG BASE

Approval Date

2004-06-09

76593 / 2

Active Ingredient

CIPROFLOXACIN HYDROCHLORIDE

Application Number

76593

Product Number

2

Dosage Form

-

Strength

EQ 250MG BASE

Approval Date

2004-06-09

Regulatory Status

RX

2004
09 Jun
RX Application: 76593

Drug Name

CIPROFLOXACIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 500MG BASE

Approval Date

2004-06-09

76593 / 3

Active Ingredient

CIPROFLOXACIN HYDROCHLORIDE

Application Number

76593

Product Number

3

Dosage Form

-

Strength

EQ 500MG BASE

Approval Date

2004-06-09

Regulatory Status

RX

2004
09 Jun
RX Application: 76593

Drug Name

CIPROFLOXACIN HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

EQ 750MG BASE

Approval Date

2004-06-09

76593 / 4

Active Ingredient

CIPROFLOXACIN HYDROCHLORIDE

Application Number

76593

Product Number

4

Dosage Form

-

Strength

EQ 750MG BASE

Approval Date

2004-06-09

Regulatory Status

RX

1991
19 Nov
Discontinued Application: 72854

Drug Name

CYCLOBENZAPRINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

1991-11-19

72854 / 1

Active Ingredient

CYCLOBENZAPRINE HYDROCHLORIDE

Application Number

72854

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

1991-11-19

Regulatory Status

Discontinued

2006
03 Feb
Discontinued Application: 72854

Drug Name

CYCLOBENZAPRINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2006-02-03

72854 / 2

Active Ingredient

CYCLOBENZAPRINE HYDROCHLORIDE

Application Number

72854

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2006-02-03

Regulatory Status

Discontinued

2026
13 May
RX Application: 72854

Drug Name

CYCLOBENZAPRINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

7.5MG

Approval Date

2026-05-13

72854 / 3

Active Ingredient

CYCLOBENZAPRINE HYDROCHLORIDE

Application Number

72854

Product Number

3

Dosage Form

-

Strength

7.5MG

Approval Date

2026-05-13

Regulatory Status

RX

2011
31 May
Discontinued Application: 90290

Drug Name

DONEPEZIL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2011-05-31

90290 / 1

Active Ingredient

DONEPEZIL HYDROCHLORIDE

Application Number

90290

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2011-05-31

Regulatory Status

Discontinued

2011
31 May
Discontinued Application: 90290

Drug Name

DONEPEZIL HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2011-05-31

90290 / 2

Active Ingredient

DONEPEZIL HYDROCHLORIDE

Application Number

90290

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2011-05-31

Regulatory Status

Discontinued

2011
10 May
Discontinued Application: 91198

Drug Name

DONEPEZIL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2011-05-10

91198 / 1

Active Ingredient

DONEPEZIL HYDROCHLORIDE

Application Number

91198

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2011-05-10

Regulatory Status

Discontinued

2011
10 May
Discontinued Application: 91198

Drug Name

DONEPEZIL HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2011-05-10

91198 / 2

Active Ingredient

DONEPEZIL HYDROCHLORIDE

Application Number

91198

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2011-05-10

Regulatory Status

Discontinued

2020
28 Jul
RX Application: 213474

Drug Name

DOXEPIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2020-07-28

213474 / 1

Active Ingredient

DOXEPIN HYDROCHLORIDE

Application Number

213474

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2020-07-28

Regulatory Status

RX

2020
28 Jul
RX Application: 213474

Drug Name

DOXEPIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

2020-07-28

213474 / 2

Active Ingredient

DOXEPIN HYDROCHLORIDE

Application Number

213474

Product Number

2

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

2020-07-28

Regulatory Status

RX

2020
28 Jul
RX Application: 213474

Drug Name

DOXEPIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2020-07-28

213474 / 3

Active Ingredient

DOXEPIN HYDROCHLORIDE

Application Number

213474

Product Number

3

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2020-07-28

Regulatory Status

RX

2020
28 Jul
RX Application: 213474

Drug Name

DOXEPIN HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2020-07-28

213474 / 4

Active Ingredient

DOXEPIN HYDROCHLORIDE

Application Number

213474

Product Number

4

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2020-07-28

Regulatory Status

RX

2020
28 Jul
RX Application: 213474

Drug Name

DOXEPIN HYDROCHLORIDE

Product Number

5

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2020-07-28

213474 / 5

Active Ingredient

DOXEPIN HYDROCHLORIDE

Application Number

213474

Product Number

5

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2020-07-28

Regulatory Status

RX

2025
01 Oct
RX Application: 219978

Drug Name

DOXYCYCLINE

Product Number

1

Dosage Form

-

Strength

40MG

Approval Date

2025-10-01

219978 / 1

Active Ingredient

DOXYCYCLINE

Application Number

219978

Product Number

1

Dosage Form

-

Strength

40MG

Approval Date

2025-10-01

Regulatory Status

RX

2001
23 Mar
RX Application: 75178

Drug Name

ENALAPRIL MALEATE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2001-03-23

75178 / 1

Active Ingredient

ENALAPRIL MALEATE

Application Number

75178

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2001-03-23

Regulatory Status

RX

2001
23 Mar
RX Application: 75178

Drug Name

ENALAPRIL MALEATE

Product Number

2

Dosage Form

-

Strength

2.5MG

Approval Date

2001-03-23

75178 / 2

Active Ingredient

ENALAPRIL MALEATE

Application Number

75178

Product Number

2

Dosage Form

-

Strength

2.5MG

Approval Date

2001-03-23

Regulatory Status

RX

2001
23 Mar
RX Application: 75178

Drug Name

ENALAPRIL MALEATE

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2001-03-23

75178 / 3

Active Ingredient

ENALAPRIL MALEATE

Application Number

75178

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2001-03-23

Regulatory Status

RX

2001
23 Mar
RX Application: 75178

Drug Name

ENALAPRIL MALEATE

Product Number

4

Dosage Form

-

Strength

20MG

Approval Date

2001-03-23

75178 / 4

Active Ingredient

ENALAPRIL MALEATE

Application Number

75178

Product Number

4

Dosage Form

-

Strength

20MG

Approval Date

2001-03-23

Regulatory Status

RX

2012
12 Sep
Discontinued Application: 77512

Drug Name

ESCITALOPRAM OXALATE

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2012-09-12

77512 / 1

Active Ingredient

ESCITALOPRAM OXALATE

Application Number

77512

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2012-09-12

Regulatory Status

Discontinued

2012
12 Sep
Discontinued Application: 77512

Drug Name

ESCITALOPRAM OXALATE

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2012-09-12

77512 / 2

Active Ingredient

ESCITALOPRAM OXALATE

Application Number

77512

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2012-09-12

Regulatory Status

Discontinued

2012
12 Sep
Discontinued Application: 77512

Drug Name

ESCITALOPRAM OXALATE

Product Number

3

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2012-09-12

77512 / 3

Active Ingredient

ESCITALOPRAM OXALATE

Application Number

77512

Product Number

3

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2012-09-12

Regulatory Status

Discontinued

2000
29 Nov
RX Application: 75888

Drug Name

FLUVOXAMINE MALEATE

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2000-11-29

75888 / 1

Active Ingredient

FLUVOXAMINE MALEATE

Application Number

75888

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2000-11-29

Regulatory Status

RX

2000
29 Nov
RX Application: 75888

Drug Name

FLUVOXAMINE MALEATE

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2000-11-29

75888 / 2

Active Ingredient

FLUVOXAMINE MALEATE

Application Number

75888

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2000-11-29

Regulatory Status

RX

2000
29 Nov
RX Application: 75888

Drug Name

FLUVOXAMINE MALEATE

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2000-11-29

75888 / 3

Active Ingredient

FLUVOXAMINE MALEATE

Application Number

75888

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2000-11-29

Regulatory Status

RX

2013
12 Jul
RX Application: 91145

Drug Name

FOLIC ACID

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

2013-07-12

91145 / 1

Active Ingredient

FOLIC ACID

Application Number

91145

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

2013-07-12

Regulatory Status

RX

1995
07 Apr
RX Application: 74305

Drug Name

GLIPIZIDE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

1995-04-07

74305 / 1

Active Ingredient

GLIPIZIDE

Application Number

74305

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

1995-04-07

Regulatory Status

RX

1995
07 Apr
RX Application: 74305

Drug Name

GLIPIZIDE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

1995-04-07

74305 / 2

Active Ingredient

GLIPIZIDE

Application Number

74305

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

1995-04-07

Regulatory Status

RX

2022
08 Jun
RX Application: 216399

Drug Name

GUANFACINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2022-06-08

216399 / 1

Active Ingredient

GUANFACINE HYDROCHLORIDE

Application Number

216399

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2022-06-08

Regulatory Status

RX

2022
08 Jun
RX Application: 216399

Drug Name

GUANFACINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2022-06-08

216399 / 2

Active Ingredient

GUANFACINE HYDROCHLORIDE

Application Number

216399

Product Number

2

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2022-06-08

Regulatory Status

RX

1987
17 Feb
Discontinued Application: 71128

Drug Name

HALOPERIDOL

Product Number

1

Dosage Form

-

Strength

0.5MG

Approval Date

1987-02-17

71128 / 1

Active Ingredient

HALOPERIDOL

Application Number

71128

Product Number

1

Dosage Form

-

Strength

0.5MG

Approval Date

1987-02-17

Regulatory Status

Discontinued

1987
17 Feb
Discontinued Application: 71129

Drug Name

HALOPERIDOL

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

1987-02-17

71129 / 1

Active Ingredient

HALOPERIDOL

Application Number

71129

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

1987-02-17

Regulatory Status

Discontinued

1987
17 Feb
RX Application: 71130

Drug Name

HALOPERIDOL

Product Number

1

Dosage Form

-

Strength

2MG

Approval Date

1987-02-17

71130 / 1

Active Ingredient

HALOPERIDOL

Application Number

71130

Product Number

1

Dosage Form

-

Strength

2MG

Approval Date

1987-02-17

Regulatory Status

RX

1987
17 Feb
RX Application: 71130

Drug Name

HALOPERIDOL

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

1987-02-17

71130 / 2

Active Ingredient

HALOPERIDOL

Application Number

71130

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

1987-02-17

Regulatory Status

RX

1987
12 May
RX Application: 71130

Drug Name

HALOPERIDOL

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

1987-05-12

71130 / 3

Active Ingredient

HALOPERIDOL

Application Number

71130

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

1987-05-12

Regulatory Status

RX

2026
08 Apr
RX Application: 71130

Drug Name

HALOPERIDOL

Product Number

4

Dosage Form

-

Strength

0.5MG

Approval Date

2026-04-08

71130 / 4

Active Ingredient

HALOPERIDOL

Application Number

71130

Product Number

4

Dosage Form

-

Strength

0.5MG

Approval Date

2026-04-08

Regulatory Status

RX

2026
08 Apr
RX Application: 71130

Drug Name

HALOPERIDOL

Product Number

5

Dosage Form

-

Strength

1MG

Approval Date

2026-04-08

71130 / 5

Active Ingredient

HALOPERIDOL

Application Number

71130

Product Number

5

Dosage Form

-

Strength

1MG

Approval Date

2026-04-08

Regulatory Status

RX

2026
08 Apr
RX Application: 71130

Drug Name

HALOPERIDOL

Product Number

6

Dosage Form

-

Strength

20MG

Approval Date

2026-04-08

71130 / 6

Active Ingredient

HALOPERIDOL

Application Number

71130

Product Number

6

Dosage Form

-

Strength

20MG

Approval Date

2026-04-08

Regulatory Status

RX

1987
12 May
Discontinued Application: 71133

Drug Name

HALOPERIDOL

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

1987-05-12

71133 / 1

Active Ingredient

HALOPERIDOL

Application Number

71133

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

1987-05-12

Regulatory Status

Discontinued

1998
04 Aug
RX Application: 75113

Drug Name

LABETALOL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

1998-08-04

75113 / 1

Active Ingredient

LABETALOL HYDROCHLORIDE

Application Number

75113

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

1998-08-04

Regulatory Status

RX

1998
04 Aug
RX Application: 75113

Drug Name

LABETALOL HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

1998-08-04

75113 / 2

Active Ingredient

LABETALOL HYDROCHLORIDE

Application Number

75113

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

1998-08-04

Regulatory Status

RX

1998
04 Aug
RX Application: 75113

Drug Name

LABETALOL HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

300MG

Approval Date

1998-08-04

75113 / 3

Active Ingredient

LABETALOL HYDROCHLORIDE

Application Number

75113

Product Number

3

Dosage Form

-

Strength

300MG

Approval Date

1998-08-04

Regulatory Status

RX

2009
27 Jan
Discontinued Application: 78645

Drug Name

LAMOTRIGINE

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2009-01-27

78645 / 1

Active Ingredient

LAMOTRIGINE

Application Number

78645

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2009-01-27

Regulatory Status

Discontinued

2009
27 Jan
Discontinued Application: 78645

Drug Name

LAMOTRIGINE

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

2009-01-27

78645 / 2

Active Ingredient

LAMOTRIGINE

Application Number

78645

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

2009-01-27

Regulatory Status

Discontinued

2009
27 Jan
Discontinued Application: 78645

Drug Name

LAMOTRIGINE

Product Number

3

Dosage Form

-

Strength

150MG

Approval Date

2009-01-27

78645 / 3

Active Ingredient

LAMOTRIGINE

Application Number

78645

Product Number

3

Dosage Form

-

Strength

150MG

Approval Date

2009-01-27

Regulatory Status

Discontinued

2009
27 Jan
Discontinued Application: 78645

Drug Name

LAMOTRIGINE

Product Number

4

Dosage Form

-

Strength

200MG

Approval Date

2009-01-27

78645 / 4

Active Ingredient

LAMOTRIGINE

Application Number

78645

Product Number

4

Dosage Form

-

Strength

200MG

Approval Date

2009-01-27

Regulatory Status

Discontinued

2016
26 Aug
RX Application: 204754

Drug Name

LEVETIRACETAM

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2016-08-26

204754 / 1

Active Ingredient

LEVETIRACETAM

Application Number

204754

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2016-08-26

Regulatory Status

RX

2016
26 Aug
RX Application: 204754

Drug Name

LEVETIRACETAM

Product Number

2

Dosage Form

-

Strength

750MG

Approval Date

2016-08-26

204754 / 2

Active Ingredient

LEVETIRACETAM

Application Number

204754

Product Number

2

Dosage Form

-

Strength

750MG

Approval Date

2016-08-26

Regulatory Status

RX

2002
01 Jul
RX Application: 76262

Drug Name

LISINOPRIL AND HYDROCHLOROTHIAZIDE

Product Number

1

Dosage Form

-

Strength

12.5MG;10MG

Approval Date

2002-07-01

76262 / 1

Active Ingredient

HYDROCHLOROTHIAZIDE; LISINOPRIL

Application Number

76262

Product Number

1

Dosage Form

-

Strength

12.5MG;10MG

Approval Date

2002-07-01

Regulatory Status

RX

2002
01 Jul
RX Application: 76262

Drug Name

LISINOPRIL AND HYDROCHLOROTHIAZIDE

Product Number

2

Dosage Form

-

Strength

12.5MG;20MG

Approval Date

2002-07-01

76262 / 2

Active Ingredient

HYDROCHLOROTHIAZIDE; LISINOPRIL

Application Number

76262

Product Number

2

Dosage Form

-

Strength

12.5MG;20MG

Approval Date

2002-07-01

Regulatory Status

RX

2002
01 Jul
RX Application: 76262

Drug Name

LISINOPRIL AND HYDROCHLOROTHIAZIDE

Product Number

3

Dosage Form

-

Strength

25MG;20MG

Approval Date

2002-07-01

76262 / 3

Active Ingredient

HYDROCHLOROTHIAZIDE; LISINOPRIL

Application Number

76262

Product Number

3

Dosage Form

-

Strength

25MG;20MG

Approval Date

2002-07-01

Regulatory Status

RX

2010
06 Oct
RX Application: 90544

Drug Name

LOSARTAN POTASSIUM

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2010-10-06

90544 / 1

Active Ingredient

LOSARTAN POTASSIUM

Application Number

90544

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2010-10-06

Regulatory Status

RX

2010
06 Oct
RX Application: 90544

Drug Name

LOSARTAN POTASSIUM

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2010-10-06

90544 / 2

Active Ingredient

LOSARTAN POTASSIUM

Application Number

90544

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2010-10-06

Regulatory Status

RX

2010
06 Oct
RX Application: 90544

Drug Name

LOSARTAN POTASSIUM

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2010-10-06

90544 / 3

Active Ingredient

LOSARTAN POTASSIUM

Application Number

90544

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2010-10-06

Regulatory Status

RX

2006
19 Jul
RX Application: 77920

Drug Name

MELOXICAM

Product Number

1

Dosage Form

-

Strength

7.5MG

Approval Date

2006-07-19

77920 / 1

Active Ingredient

MELOXICAM

Application Number

77920

Product Number

1

Dosage Form

-

Strength

7.5MG

Approval Date

2006-07-19

Regulatory Status

RX

2006
19 Jul
RX Application: 77920

Drug Name

MELOXICAM

Product Number

2

Dosage Form

-

Strength

15MG

Approval Date

2006-07-19

77920 / 2

Active Ingredient

MELOXICAM

Application Number

77920

Product Number

2

Dosage Form

-

Strength

15MG

Approval Date

2006-07-19

Regulatory Status

RX

2005
18 Feb
RX Application: 40547

Drug Name

METHIMAZOLE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2005-02-18

40547 / 1

Active Ingredient

METHIMAZOLE

Application Number

40547

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2005-02-18

Regulatory Status

RX

2005
18 Feb
RX Application: 40547

Drug Name

METHIMAZOLE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2005-02-18

40547 / 2

Active Ingredient

METHIMAZOLE

Application Number

40547

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2005-02-18

Regulatory Status

RX

2005
18 Feb
Discontinued Application: 40547

Drug Name

METHIMAZOLE

Product Number

4

Dosage Form

-

Strength

20MG

Approval Date

2005-02-18

40547 / 4

Active Ingredient

METHIMAZOLE

Application Number

40547

Product Number

4

Dosage Form

-

Strength

20MG

Approval Date

2005-02-18

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 84615

Drug Name

METHOCARBAMOL

Product Number

1

Dosage Form

-

Strength

750MG

Approval Date

1982-01-01

84615 / 1

Active Ingredient

METHOCARBAMOL

Application Number

84615

Product Number

1

Dosage Form

-

Strength

750MG

Approval Date

1982-01-01

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 84616

Drug Name

METHOCARBAMOL

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

1982-01-01

84616 / 1

Active Ingredient

METHOCARBAMOL

Application Number

84616

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

1982-01-01

Regulatory Status

Discontinued

1990
30 Jan
RX Application: 72215

Drug Name

METOCLOPRAMIDE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

1990-01-30

72215 / 1

Active Ingredient

METOCLOPRAMIDE HYDROCHLORIDE

Application Number

72215

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

1990-01-30

Regulatory Status

RX

2024
05 Nov
RX Application: 72215

Drug Name

METOCLOPRAMIDE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2024-11-05

72215 / 2

Active Ingredient

METOCLOPRAMIDE HYDROCHLORIDE

Application Number

72215

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2024-11-05

Regulatory Status

RX

2012
03 Aug
Discontinued Application: 91414

Drug Name

MONTELUKAST SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 4MG BASE

Approval Date

2012-08-03

91414 / 1

Active Ingredient

MONTELUKAST SODIUM

Application Number

91414

Product Number

1

Dosage Form

-

Strength

EQ 4MG BASE

Approval Date

2012-08-03

Regulatory Status

Discontinued

2012
03 Aug
Discontinued Application: 91414

Drug Name

MONTELUKAST SODIUM

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2012-08-03

91414 / 2

Active Ingredient

MONTELUKAST SODIUM

Application Number

91414

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2012-08-03

Regulatory Status

Discontinued

1996
31 Jul
RX Application: 74625

Drug Name

OXYBUTYNIN CHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

1996-07-31

74625 / 1

Active Ingredient

OXYBUTYNIN CHLORIDE

Application Number

74625

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

1996-07-31

Regulatory Status

RX

2013
13 Feb
RX Application: 78670

Drug Name

PIOGLITAZONE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 15MG BASE

Approval Date

2013-02-13

78670 / 1

Active Ingredient

PIOGLITAZONE HYDROCHLORIDE

Application Number

78670

Product Number

1

Dosage Form

-

Strength

EQ 15MG BASE

Approval Date

2013-02-13

Regulatory Status

RX

2013
13 Feb
RX Application: 78670

Drug Name

PIOGLITAZONE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

2013-02-13

78670 / 2

Active Ingredient

PIOGLITAZONE HYDROCHLORIDE

Application Number

78670

Product Number

2

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

2013-02-13

Regulatory Status

RX

2013
13 Feb
RX Application: 78670

Drug Name

PIOGLITAZONE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 45MG BASE

Approval Date

2013-02-13

78670 / 3

Active Ingredient

PIOGLITAZONE HYDROCHLORIDE

Application Number

78670

Product Number

3

Dosage Form

-

Strength

EQ 45MG BASE

Approval Date

2013-02-13

Regulatory Status

RX

1982
01 Jan
Discontinued Application: 80336

Drug Name

PREDNISONE

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

1982-01-01

80336 / 2

Active Ingredient

PREDNISONE

Application Number

80336

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

1982-01-01

Regulatory Status

Discontinued

2025
28 Jan
RX Application: 217857

Drug Name

PREGABALIN

Product Number

1

Dosage Form

-

Strength

330MG

Approval Date

2025-01-28

217857 / 1

Active Ingredient

PREGABALIN

Application Number

217857

Product Number

1

Dosage Form

-

Strength

330MG

Approval Date

2025-01-28

Regulatory Status

RX

2026
24 Jun
RX Application: 217857

Drug Name

PREGABALIN

Product Number

2

Dosage Form

-

Strength

165MG

Approval Date

2026-06-24

217857 / 2

Active Ingredient

PREGABALIN

Application Number

217857

Product Number

2

Dosage Form

-

Strength

165MG

Approval Date

2026-06-24

Regulatory Status

RX

1996
22 Feb
RX Application: 73263

Drug Name

PREVALITE

Product Number

1

Dosage Form

-

Strength

EQ 4GM RESIN/PACKET

Approval Date

1996-02-22

73263 / 1

Active Ingredient

CHOLESTYRAMINE

Application Number

73263

Product Number

1

Dosage Form

-

Strength

EQ 4GM RESIN/PACKET

Approval Date

1996-02-22

Regulatory Status

RX

1997
30 Oct
RX Application: 73263

Drug Name

PREVALITE

Product Number

2

Dosage Form

-

Strength

EQ 4GM RESIN/SCOOPFUL

Approval Date

1997-10-30

73263 / 2

Active Ingredient

CHOLESTYRAMINE

Application Number

73263

Product Number

2

Dosage Form

-

Strength

EQ 4GM RESIN/SCOOPFUL

Approval Date

1997-10-30

Regulatory Status

RX

1986
22 Oct
Discontinued Application: 71288

Drug Name

PROPRANOLOL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

90MG

Approval Date

1986-10-22

71288 / 1

Active Ingredient

PROPRANOLOL HYDROCHLORIDE

Application Number

71288

Product Number

1

Dosage Form

-

Strength

90MG

Approval Date

1986-10-22

Regulatory Status

Discontinued

2025
14 May
RX Application: 216995

Drug Name

RIVAROXABAN

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2025-05-14

216995 / 1

Active Ingredient

RIVAROXABAN

Application Number

216995

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2025-05-14

Regulatory Status

RX

2025
14 May
RX Application: 216995

Drug Name

RIVAROXABAN

Product Number

2

Dosage Form

-

Strength

15MG

Approval Date

2025-05-14

216995 / 2

Active Ingredient

RIVAROXABAN

Application Number

216995

Product Number

2

Dosage Form

-

Strength

15MG

Approval Date

2025-05-14

Regulatory Status

RX

2025
14 May
RX Application: 216995

Drug Name

RIVAROXABAN

Product Number

3

Dosage Form

-

Strength

20MG

Approval Date

2025-05-14

216995 / 3

Active Ingredient

RIVAROXABAN

Application Number

216995

Product Number

3

Dosage Form

-

Strength

20MG

Approval Date

2025-05-14

Regulatory Status

RX

2001
27 Apr
RX Application: 75500

Drug Name

SORINE

Product Number

1

Dosage Form

-

Strength

80MG

Approval Date

2001-04-27

75500 / 1

Active Ingredient

SOTALOL HYDROCHLORIDE

Application Number

75500

Product Number

1

Dosage Form

-

Strength

80MG

Approval Date

2001-04-27

Regulatory Status

RX

2001
27 Apr
RX Application: 75500

Drug Name

SORINE

Product Number

2

Dosage Form

-

Strength

160MG

Approval Date

2001-04-27

75500 / 2

Active Ingredient

SOTALOL HYDROCHLORIDE

Application Number

75500

Product Number

2

Dosage Form

-

Strength

160MG

Approval Date

2001-04-27

Regulatory Status

RX

2001
27 Apr
RX Application: 75500

Drug Name

SORINE

Product Number

3

Dosage Form

-

Strength

240MG

Approval Date

2001-04-27

75500 / 3

Active Ingredient

SOTALOL HYDROCHLORIDE

Application Number

75500

Product Number

3

Dosage Form

-

Strength

240MG

Approval Date

2001-04-27

Regulatory Status

RX

2001
27 Apr
RX Application: 75500

Drug Name

SORINE

Product Number

4

Dosage Form

-

Strength

120MG

Approval Date

2001-04-27

75500 / 4

Active Ingredient

SOTALOL HYDROCHLORIDE

Application Number

75500

Product Number

4

Dosage Form

-

Strength

120MG

Approval Date

2001-04-27

Regulatory Status

RX

1986
13 Nov
Discontinued Application: 70890

Drug Name

SULFAMETHOXAZOLE AND TRIMETHOPRIM

Product Number

1

Dosage Form

-

Strength

800MG;160MG

Approval Date

1986-11-13

70890 / 1

Active Ingredient

SULFAMETHOXAZOLE; TRIMETHOPRIM

Application Number

70890

Product Number

1

Dosage Form

-

Strength

800MG;160MG

Approval Date

1986-11-13

Regulatory Status

Discontinued

1986
13 Nov
Discontinued Application: 70890

Drug Name

SULFAMETHOXAZOLE AND TRIMETHOPRIM

Product Number

2

Dosage Form

-

Strength

400MG;80MG

Approval Date

1986-11-13

70890 / 2

Active Ingredient

SULFAMETHOXAZOLE; TRIMETHOPRIM

Application Number

70890

Product Number

2

Dosage Form

-

Strength

400MG;80MG

Approval Date

1986-11-13

Regulatory Status

Discontinued

2010
07 Jan
Discontinued Application: 78499

Drug Name

TOPIRAMATE

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2010-01-07

78499 / 1

Active Ingredient

TOPIRAMATE

Application Number

78499

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2010-01-07

Regulatory Status

Discontinued

2010
07 Jan
Discontinued Application: 78499

Drug Name

TOPIRAMATE

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2010-01-07

78499 / 2

Active Ingredient

TOPIRAMATE

Application Number

78499

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2010-01-07

Regulatory Status

Discontinued

2010
07 Jan
Discontinued Application: 78499

Drug Name

TOPIRAMATE

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2010-01-07

78499 / 3

Active Ingredient

TOPIRAMATE

Application Number

78499

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2010-01-07

Regulatory Status

Discontinued

2010
07 Jan
Discontinued Application: 78499

Drug Name

TOPIRAMATE

Product Number

4

Dosage Form

-

Strength

200MG

Approval Date

2010-01-07

78499 / 4

Active Ingredient

TOPIRAMATE

Application Number

78499

Product Number

4

Dosage Form

-

Strength

200MG

Approval Date

2010-01-07

Regulatory Status

Discontinued

1990
30 Apr
Discontinued Application: 72483

Drug Name

TRAZODONE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

1990-04-30

72483 / 1

Active Ingredient

TRAZODONE HYDROCHLORIDE

Application Number

72483

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

1990-04-30

Regulatory Status

Discontinued

2010
24 May
Discontinued Application: 77478

Drug Name

VALACYCLOVIR HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE

Approval Date

2010-05-24

77478 / 1

Active Ingredient

VALACYCLOVIR HYDROCHLORIDE

Application Number

77478

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE

Approval Date

2010-05-24

Regulatory Status

Discontinued

2010
24 May
Discontinued Application: 77478

Drug Name

VALACYCLOVIR HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 1GM BASE

Approval Date

2010-05-24

77478 / 2

Active Ingredient

VALACYCLOVIR HYDROCHLORIDE

Application Number

77478

Product Number

2

Dosage Form

-

Strength

EQ 1GM BASE

Approval Date

2010-05-24

Regulatory Status

Discontinued

2013
27 Jun
Discontinued Application: 200104

Drug Name

WARFARIN SODIUM

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

2013-06-27

200104 / 1

Active Ingredient

WARFARIN SODIUM

Application Number

200104

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

2013-06-27

Regulatory Status

Discontinued

2013
27 Jun
Discontinued Application: 200104

Drug Name

WARFARIN SODIUM

Product Number

2

Dosage Form

-

Strength

2MG

Approval Date

2013-06-27

200104 / 2

Active Ingredient

WARFARIN SODIUM

Application Number

200104

Product Number

2

Dosage Form

-

Strength

2MG

Approval Date

2013-06-27

Regulatory Status

Discontinued

2013
27 Jun
Discontinued Application: 200104

Drug Name

WARFARIN SODIUM

Product Number

3

Dosage Form

-

Strength

2.5MG

Approval Date

2013-06-27

200104 / 3

Active Ingredient

WARFARIN SODIUM

Application Number

200104

Product Number

3

Dosage Form

-

Strength

2.5MG

Approval Date

2013-06-27

Regulatory Status

Discontinued

2013
27 Jun
Discontinued Application: 200104

Drug Name

WARFARIN SODIUM

Product Number

4

Dosage Form

-

Strength

3MG

Approval Date

2013-06-27

200104 / 4

Active Ingredient

WARFARIN SODIUM

Application Number

200104

Product Number

4

Dosage Form

-

Strength

3MG

Approval Date

2013-06-27

Regulatory Status

Discontinued

2013
27 Jun
Discontinued Application: 200104

Drug Name

WARFARIN SODIUM

Product Number

5

Dosage Form

-

Strength

4MG

Approval Date

2013-06-27

200104 / 5

Active Ingredient

WARFARIN SODIUM

Application Number

200104

Product Number

5

Dosage Form

-

Strength

4MG

Approval Date

2013-06-27

Regulatory Status

Discontinued

2013
27 Jun
Discontinued Application: 200104

Drug Name

WARFARIN SODIUM

Product Number

6

Dosage Form

-

Strength

5MG

Approval Date

2013-06-27

200104 / 6

Active Ingredient

WARFARIN SODIUM

Application Number

200104

Product Number

6

Dosage Form

-

Strength

5MG

Approval Date

2013-06-27

Regulatory Status

Discontinued

2013
27 Jun
Discontinued Application: 200104

Drug Name

WARFARIN SODIUM

Product Number

7

Dosage Form

-

Strength

6MG

Approval Date

2013-06-27

200104 / 7

Active Ingredient

WARFARIN SODIUM

Application Number

200104

Product Number

7

Dosage Form

-

Strength

6MG

Approval Date

2013-06-27

Regulatory Status

Discontinued

2013
27 Jun
Discontinued Application: 200104

Drug Name

WARFARIN SODIUM

Product Number

8

Dosage Form

-

Strength

7.5MG

Approval Date

2013-06-27

200104 / 8

Active Ingredient

WARFARIN SODIUM

Application Number

200104

Product Number

8

Dosage Form

-

Strength

7.5MG

Approval Date

2013-06-27

Regulatory Status

Discontinued

2013
27 Jun
Discontinued Application: 200104

Drug Name

WARFARIN SODIUM

Product Number

9

Dosage Form

-

Strength

10MG

Approval Date

2013-06-27

200104 / 9

Active Ingredient

WARFARIN SODIUM

Application Number

200104

Product Number

9

Dosage Form

-

Strength

10MG

Approval Date

2013-06-27

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    141 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
141 total
  • Discontinued
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE

Application Number

76867

Product Number

1

Active Ingredient

ALBUTEROL SULFATE; IPRATROPIUM BROMIDE

Dosage Form

-

Strength

EQ 0.083% BASE;0.017%

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.